|
OVERVIEW
|
|
|
|
|
|
|
|
AWARDS
|
|
|
|
LaGray has actively
participated in a number
of meetings, workshops
and conferences aimed at
improving health in
sub-Saharan Africa.
The company's
participation includes
presentations,
exhibitions, panel
discussions and
workshops.
LaGray has also
sponsored meetings,
sessions and has chaired
panel and other forms of
discussions.
The company has received
recognition and awards
as a pioneer, for
entrepreneurism and for
scientific merit.
For more information, go
to the following pages:
|
|
 |
 |
|
LaGray signed a
technology transfer agreement with
Anuh Pharma of Mumbai, India in
April 2007.
The agreement covers the supply of
synthetic intermediates to LaGray
and technology transfer
for API production
|
| |
|
|
 |
|
LaGray started
its first commercial production of azithromycin
in August 2008. This marked the
first commercial manufacture of APIs in West
Africa. Dr. Graham, COO of the
company announced that plans are
under way for
manufacture of essential antimalarial and antiretroviral APIs
by the third quarter of 2009.
|
| |
|
|
 |
|
Mr. Harish Poojary,
Manager Plant and Facilities at
LaGray announced on August 4th
2008 that construction and equipment
installation of the company's new state of the art
oral solid dosage form plant has
been completed.
This concludes Phase II A of the
company's development plans, which adds capacity
for the production of oral capsules,
tablets and powders. |
For answers to specific questions,
help researching a technology or
industry-related topic, or to set up an
interview with LaGray please
contact:
Accra, Ghana
TopDogCommunication
+233 28 911 4783
wo@topdogcommunications.com
Chicago, USA
Murad
Sabzali
312-997-2436
msabzali@chempetitive.com
|
